Advertisement

Infective Endocarditis Prophylaxis and Prevention

  • Xavier Duval
Chapter

Abstract

Due to the high rate of mortality and morbidity of infective endocarditis, every effort should be made to reduce its incidence. Although its efficacy has not been demonstrated in humans, antibiotic prophylaxis had been recommended since 60 years for subjects with predisposing conditions undergoing at-risk procedures. This article discusses the pro and con of the ongoing IE prophylaxis strategies and the impact of the recent modifications on the disease incidence.

Keywords

Endocarditis Prophylaxis Antibiotic Evolution 

References

  1. 1.
    Hoen B, Alla F, Selton-Suty C, et al. Changing profile of infective endocarditis: results of a 1-year survey in France. JAMA. 2002;288(1):75–81.CrossRefPubMedGoogle Scholar
  2. 2.
    Hoen B, Duval X. Infective endocarditis. N Engl J Med. 2013;368:1425–33.CrossRefPubMedGoogle Scholar
  3. 3.
    Tleyjeh IM, Steckelberg JM, Murad HS, et al. Temporal trends in infective endocarditis: a population-based study in Olmsted County, Minnesota. JAMA. 2005;293(24):3022–8.CrossRefPubMedGoogle Scholar
  4. 4.
    Selton-Suty C, Celard M, Le Moing V, et al. Preeminence of Staphylococcus aureus in infective endocarditis: a 1-year population-based survey. Clin Infect Dis. 2012;54(9):1230–9.CrossRefPubMedGoogle Scholar
  5. 5.
    American Heart Association. Prevention of rheumatic fever and bacterial endocarditis through control of streptococcal infections. Circulation. 1955;11:317–20.Google Scholar
  6. 6.
    Dajani AS, Taubert KA, Wilson W, et al. Prevention of bacterial endocarditis. Recommendations by the American Heart Association. JAMA. 1997;277(22):1794–801.CrossRefPubMedGoogle Scholar
  7. 7.
    Baddour LM. Prophylaxis of infective endocarditis: prevention of the perfect storm. Int J Antimicrob Agents. 2007;30 Suppl 1:S37–41.CrossRefPubMedGoogle Scholar
  8. 8.
    Duval X, Delahaye F, Alla F, et al. Temporal trends in infective endocarditis in the context of prophylaxis guideline modifications: three successive population-based surveys. J Am Coll Cardiol. 2012;59(22):1968–76.CrossRefPubMedGoogle Scholar
  9. 9.
    Tleyjeh IM, Abdel-Latif A, Rahbi H, et al. A systematic review of population-based studies of infective endocarditis. Chest. 2007;132(3):1025–35.CrossRefPubMedGoogle Scholar
  10. 10.
    Fedeli U, Schievano E, Buonfrate D, et al. Increasing incidence and mortality of infective endocarditis: a population-based study through a record-linkage system. BMC Infect Dis. 2011;11:48.CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Federspiel JJ, Stearns SC, Peppercorn AF, et al. Increasing US rates of endocarditis with Staphylococcus aureus: 1999-2008. Arch Intern Med. 2012;172(4):363–5.CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Finland M, Barnes MW. Changing etiology of bacterial endocarditis in the antibacterial era. Experiences at Boston City Hospital 1933-1965. Ann Intern Med. 1970;72(3):341–8.CrossRefPubMedGoogle Scholar
  13. 13.
    Seckeler MD, Hoke TR. The worldwide epidemiology of acute rheumatic fever and rheumatic heart disease. Clin Epidemiol. 2011;3:67–84.CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Murdoch DR, Corey GR, Hoen B, et al. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study. Arch Intern Med. 2009;169(5):463–73.CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Correa de Sa DD, Tleyjeh IM, Anavekar NS, et al. Epidemiological trends of infective endocarditis: a population-based study in Olmsted County, Minnesota. Mayo Clin Proc. 2010;85(5):422–6.CrossRefPubMedGoogle Scholar
  16. 16.
    Lacassin F, Hoen B, Leport C, et al. Procedures associated with infective endocarditis in adults. A case control study. Eur Heart J. 1995;16(12):1968–74.PubMedGoogle Scholar
  17. 17.
    Strom BL, Abrutyn E, Berlin JA, et al. Risk factors for infective endocarditis: oral hygiene and nondental exposures. Circulation. 2000;102(23):2842–8.CrossRefPubMedGoogle Scholar
  18. 18.
    Van der Meer JT, Van Wijk W, Thompson J, et al. Efficacy of antibiotic prophylaxis for prevention of native-valve endocarditis. Lancet. 1992;339(8786):135–9.CrossRefPubMedGoogle Scholar
  19. 19.
    Duval X, Leport C. Prophylaxis of infective endocarditis: current tendencies, continuing controversies. Lancet Infect Dis. 2008;8(4):225–32.CrossRefPubMedGoogle Scholar
  20. 20.
    Drangsholt MT. A new causal model of dental diseases associated with endocarditis. Ann Periodontol. 1998;3(1):184–96.CrossRefPubMedGoogle Scholar
  21. 21.
    Roberts GJ. Dentists are innocent! “Everyday” bacteremia is the real culprit: a review and assessment of the evidence that dental surgical procedures are a principal cause of bacterial endocarditis in children. Pediatr Cardiol. 1999;20(5):317–25.CrossRefPubMedGoogle Scholar
  22. 22.
    Durack DT. Antibiotics for prevention of endocarditis during dentistry: time to scale back? Ann Intern Med. 1998;129(10):829–31.CrossRefPubMedGoogle Scholar
  23. 23.
    Duval X, Alla F, Hoen B, et al. Estimated risk of endocarditis in adults with predisposing cardiac conditions undergoing dental procedures with or without antibiotic prophylaxis. Clin Infect Dis. 2006;42(12):e102–7.CrossRefPubMedGoogle Scholar
  24. 24.
    Danchin N, Duval X, Leport C. Prophylaxis of infective endocarditis: French recommendations 2002. Heart. 2005;91(6):715–8.CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Wilson W, Taubert KA, Gewitz M, et al. Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation. 2007;116:1736–54.CrossRefPubMedGoogle Scholar
  26. 26.
    Stokes T, Richey R, Wray D. Prophylaxis against infective endocarditis: summary of NICE guidance. Heart. 2008;94(7):930–1.CrossRefPubMedGoogle Scholar
  27. 27.
    Habib G, Hoen B, Tornos P, et al. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Eur Heart J. 2009;30(19):2369–413.CrossRefPubMedGoogle Scholar
  28. 28.
    Shaw D, Conway DI. Pascal’s Wager, infective endocarditis and the “no-lose” philosophy in medicine. Heart. 2010;96(1):15–8.CrossRefPubMedGoogle Scholar
  29. 29.
    Lee P, Shanson D. Results of a UK survey of fatal anaphylaxis after oral amoxicillin. J Antimicrob Chemother. 2007;60(5):1172–3.CrossRefPubMedGoogle Scholar
  30. 30.
    Moreillon P, Overholser CD, Malinverni R, et al. Predictors of endocarditis in isolates from cultures of blood following dental extractions in rats with periodontal disease. J Infect Dis. 1988;157(5):990–5.CrossRefPubMedGoogle Scholar
  31. 31.
    Lockhart PB, Brennan MT, Sasser HC, et al. Bacteremia associated with toothbrushing and dental extraction. Circulation. 2008;117(24):3118–25.CrossRefPubMedPubMedCentralGoogle Scholar
  32. 32.
    Veloso TR, Amiguet M, Rousson V, et al. Induction of experimental endocarditis by continuous low-grade bacteremia mimicking spontaneous bacteremia in humans. Infect Immun. 2011;79(5):2006–11.CrossRefPubMedPubMedCentralGoogle Scholar
  33. 33.
    Lockhart PB. An analysis of bacteremias during dental extractions. A double-blind, placebo-controlled study of chlorhexidine. Arch Intern Med. 1996;156(5):513–20.CrossRefPubMedGoogle Scholar
  34. 34.
    Lockhart PB, Brennan MT, Kent ML, et al. Impact of amoxicillin prophylaxis on the incidence, nature, and duration of bacteremia in children after intubation and dental procedures. Circulation. 2004;109(23):2878–84.CrossRefPubMedGoogle Scholar
  35. 35.
    Lockhart PB, Brennan MT, Thornhill M, et al. Poor oral hygiene as a risk factor for infective endocarditis-related bacteremia. J Am Dent Assoc. 2009;140(10):1238–44.CrossRefPubMedPubMedCentralGoogle Scholar
  36. 36.
    Rogers AM, Schiller NB. Impact of the first nine months of revised infective endocarditis prophylaxis guidelines at a university hospital: so far so good. J Am Soc Echocardiogr. 2008;21(6):775.CrossRefPubMedGoogle Scholar
  37. 37.
    Bor DH, Woolhandler S, Nardin R, et al. Infective endocarditis in the U.S., 1998-2009: a nationwide study. PLoS One. 2013;8(3):e60033.CrossRefPubMedPubMedCentralGoogle Scholar
  38. 38.
    Desimone DC, Tleyjeh IM, Correa de Sa DD, et al. Incidence of infective endocarditis caused by viridans group streptococci before and after publication of the 2007 American Heart Association’s endocarditis prevention guidelines. Circulation. 2012;126(1):60–4.CrossRefPubMedPubMedCentralGoogle Scholar
  39. 39.
    Pasquali SK, He X, Mohamad Z, et al. Trends in endocarditis hospitalizations at US children’s hospitals: impact of the 2007 American Heart Association Antibiotic Prophylaxis Guidelines. Am Heart J. 2012;163(5):894–9.CrossRefPubMedPubMedCentralGoogle Scholar
  40. 40.
    Bikdeli B, Wang Y, Kim N, et al. Trends in hospitalization rates and outcomes of endocarditis among Medicare beneficiaries. J Am Coll Cardiol. 2013;62(23):2217–26.CrossRefPubMedPubMedCentralGoogle Scholar
  41. 41.
    Pant S, Patel N, Deshmukh A. Trends in infective endocarditis incidence, microbiology and valve replacement in the United States from 2000-2011. J Am Coll Cardiol. 2015;65:2070–6.Google Scholar
  42. 42.
    Thornhill MH, Dayer MJ, Forde JM, et al. Impact of the NICE guideline recommending cessation of antibiotic prophylaxis for prevention of infective endocarditis: before and after study. BMJ. 2011;342:d2392.CrossRefPubMedPubMedCentralGoogle Scholar
  43. 43.
    Dayer MJ, Jones S, Prendergast B, et al. An increase in the incidence of infective endocarditis in England since 2008: a secular trend interrupted time series analysis. Lancet. 2015;385(9974):1219–28.CrossRefPubMedGoogle Scholar
  44. 44.
    Duval X, Alla F, Hoen B. Incidence of infective endocarditis caused by viridans group streptococci before and after publication of the 2007 American Heart Association’s endocarditis prevention guidelines. Circulation. 2013;127(12):e520.CrossRefPubMedGoogle Scholar
  45. 45.
    Duval X, Selton-Suty C, Alla F, et al. Endocarditis in patients with a permanent pacemaker: a 1-year epidemiological survey on infective endocarditis due to valvular and/or pacemaker infection. Clin Infect Dis. 2004;39(1):68–74.CrossRefPubMedGoogle Scholar
  46. 46.
    Da Costa A, Kirkorian G, Cucherat M, et al. Antibiotic prophylaxis for permanent pacemaker implantation: a meta-analysis. Circulation. 1998;97(18):1796–801.CrossRefPubMedGoogle Scholar
  47. 47.
    de Oliveira JC, Martinelli M, Nishioka SA, et al. Efficacy of antibiotic prophylaxis before the implantation of pacemakers and cardioverter-defibrillators: results of a large, prospective, randomized, double-blinded, placebo-controlled trial. Circ Arrhythm Electrophysiol. 2009;2(1):29–34.CrossRefPubMedGoogle Scholar
  48. 48.
    Baddour LM, Bettmann MA, Bolger AF, et al. Nonvalvular cardiovascular device-related infections. Circulation. 2003;108(16):2015–31.CrossRefPubMedGoogle Scholar
  49. 49.
    Baddour LM, Epstein AE, Erickson CC, et al. Update on cardiovascular implantable electronic device infections and their management: a scientific statement from the American Heart Association. Circulation. 2010;121(3):458–77.CrossRefPubMedGoogle Scholar
  50. 50.
    Habib G, Lancellotti P, Antunes MJ, Bongiorni MG, Casalta JP, Del Zotti F, et al. ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J. 2015;36(44):3075–128.Google Scholar
  51. 51.
    Prophylaxis against infective endocarditis: antimicrobial prophylaxis against infective endocarditis in adults and children undergoing interventional procedures; NICE 2015; Available at: https://www.nice.org.uk/guidance/cg64/chapter/Recommendations

Copyright information

© Springer International Publishing Switzerland 2016

Authors and Affiliations

  1. 1.Department of Infectious DiseasesBichat Claude Bernard University HospitalParisFrance

Personalised recommendations